Question · asked by 1 review

CR oxycodone vs CR morphine: Drowsiness/somnolence (Event rate during treatment, length of treatment varied across trials)

Population
adults with cancer‐related pain
Intervention
CR oxycodone
Comparison
CR morphine
Outcome
Drowsiness/somnolence (Event rate during treatment, length of treatment varied across trials)

CR oxycodone showed no clear difference in drowsiness/somnolence (Event rate during treatment, length of… compared with CR morphine (low certainty).

What each review found

Include earlier review versions
FindingEffectStudiesGRADE certainty
CR oxycodone vs CR morphine
Drowsiness/somnolence (Event rate during treatment, length of treatment varied across trials) · adults with cancer‐related pain
CR oxycodone showed no clear difference in drowsiness/somnolence (Event rate during treatment, length of… compared with CR morphine (low certainty).
Oxycodone for cancer‐related pain (2022) · Cochrane Headline outcomes only
RR 0.88 [0.74, 1.05]15 studies · 1486 participantsLow

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Oxycodone for cancer‐related pain
2022 · Cochrane Headline outcomes only
Not reportedNot extractedNot assessed

The same intervention and outcome, asked in another population or against another comparator.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.